Adam J DiPippo

10PUBLICATIONS
16CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 09, 2023
Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center.

Alicia McGhie, Jenessa Lee, Alessandra Ferrajoli

|Jun 27, 2022
Real-life incidence of thrombotic events in leukemia patients treated with ponatinib.

E Dan Nichols, Elias Jabbour, Nadya Jammal

|Oct 05, 2021
Targeting CD123 in BPDCN: an emerging field.

Adam J DiPippo, Nathaniel R Wilson, Naveen Pemmaraju

|Sep 27, 2021
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy.

Adam J DiPippo, Patrick M McDaneld, Frank P Tverdek

Pageof 2